Ardea Biosciences, Inc. (RDEA) Reports Q3 Loss of $0.84, Sales Miss Expectations
Tweet
Share
E-mailGet Alerts RDEA Hot Sheet
Price: $31.96 --0%
Financial Fact:
Reimbursable research and development costs: 326K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Reimbursable research and development costs: 326K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q3 EPS of ($0.84), $0.17 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.95 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
